Skip to main content

Advertisement

Log in

Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

We tested the ability of retrocyclin 2, a type of θ defensin, to protect cells and chicken embryos from infection by H5N1 highly pathogenic avian influenza virus. A gene fragment of retrocyclin 2 was designed based on the protein sequence of retrocyclin 2 and cloned into the eukaryotic expression vector pcDNA4.01 (HismaxA), named pcDNA4-RC2. The expression vector pcDNA4-RC2 protected MDCK cells and chicken embryos from infection by the H5N1 virus through inhibition of virus replication and viral mRNA transcription. Retrocyclin 2 is therefore effective in preventing H5N1 virus infection in vivo and in vitro and could be considered as a new therapy for H5N1 influenza and other diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Barry DG, Daly NL, Clark RJ et al (2003) Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activity. Biochemistry 42:6688–6695

    Article  CAS  PubMed  Google Scholar 

  • Cole AM, Hong T, Boo LM et al (2002) Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci USA 99:1813–1818

    Article  CAS  PubMed  Google Scholar 

  • Craik DJ, Daly NL, Saska I et al (2003) Structures of naturally occurring circular proteins from bacteria. J Bacteriol 185:4011–4021

    Article  CAS  PubMed  Google Scholar 

  • Doss M, White MR, Tecle T et al (2009) Interactions of α-, β-, and θ-defensins with Influenza A virus and surfactant protein D. J Immunol 182:7878–7887

    Article  CAS  PubMed  Google Scholar 

  • Ge Q, McManus M, Nguyen T et al (2003) RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viralRNA transcription. Proc Natl Acad Sci USA 100:2718–2723

    Article  CAS  PubMed  Google Scholar 

  • Kim C, Gajendran N, Mittrucker H et al (2005) Human α-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci USA 102:4830–4835

    Article  CAS  PubMed  Google Scholar 

  • Munk C, Wei G, Yang OO et al (2003) The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retrovir 19:875–881

    Article  PubMed  Google Scholar 

  • Nguyen TX, Cole AM, Lehrer RI (2003) Evolution of primate θ-defensins: a serpentine path to a sweet tooth. Peptides 24:1647–1654

    Article  CAS  PubMed  Google Scholar 

  • Rosengren KJ, Daly NL, Plan MR et al (2003) Twists, knots, and rings in proteins. Structural definition of the cyclotide framework. J Biol Chem 278:8606–8616

    Article  CAS  PubMed  Google Scholar 

  • Tang YQ, Yuan J, Osapay G et al (1999) A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 286:498–502

    Article  CAS  PubMed  Google Scholar 

  • Trabi M, Schirra HJ, Craik DJ (2001) Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from rhesus macaque leukocytes. Biochemistry 40:4211–4221

    Article  CAS  PubMed  Google Scholar 

  • Wang W, Cole AM, Hong T et al (2003) Retrocyclin, an antiretroviral theta-defensin, is a lectin. J Immunol 170:4708–4716

    CAS  PubMed  Google Scholar 

  • WHO (2009) Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. http://www.who.int/csr/disease/avian_influenza/country/cases_table_2009_06_02/en/index.html

  • Yasin B, Wang W, Pang M et al (2004) θ Defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 78:5147–5156

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by grants from CAS Innovation Program (KSCX2-YW-N-063), Hi-Tech Research and development program of China (863program) (2007AA100606), National Key Basic Research and Development Program of China (9732007BC109103), USDA and IDRC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hong-xuan He.

Additional information

Qing-long Liang and Kai Zhou are co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liang, Ql., Zhou, K. & He, Hx. Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro. Biotechnol Lett 32, 387–392 (2010). https://doi.org/10.1007/s10529-009-0167-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-009-0167-2

Keywords

Navigation